← SynDRA
2-cyano-3-(3,4-dihydroxyphenyl)acrylamide
SynDRA canonical compound SYN1949091 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | EGFR |
| Mechanism of action | tyrosine kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- tyrosine kinase inhibitor
- EGFR INHIBITOR
Cross-references
Synonyms
- Tyrphostin 46
- Tyrphostin A46
- AG-99
- Tyrphostin B40
- alpha-Cyano-(3,4-dihydroxy)cinnamide
- 3,4-Dihydroxy-alpha-cyanocinnamamide
- UNII-ARL2OF9022
- CHEMBL296407
- ARL2OF9022
- Tyrphostin AG 99
- (E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide
- NSC666250
- NSC 666250
- 2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-
- (~{E})-3-[3,4-bis(oxidanyl)phenyl]-2-cyano-prop-2-enamide
- Tyrphostin AG99
- 3,4-Dihydroxy-alpha-cyanocinnamide
- Tocris-0497
- Tyrphostin deriv. 40
- BiomolKI_000013
- AC1NS5AR
Look up 2-cyano-3-(3,4-dihydroxyphenyl)acrylamide in the interactive SynDRA portal →